SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Action Construction Equipment Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 15,115.83 Crore) operating in Engineering sector. Action Construction Equipment Ltd ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

If you love Action/Adventure and you're looking for your next family favorite, you're in the right place. We've compiled a top list of the latest and greatest Action/Adventure Movies. Give it a scroll ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...